메뉴 건너뛰기




Volumn 38, Issue 2, 2014, Pages 228-234

TNF-α expression in tumor cells as a novel prognostic marker for diffuse large B-cell lymphoma, not otherwise specified

Author keywords

diffuse large B cell lymphoma; immunohistochemistry; not otherwise specified; prognostic factors; tumor necrosis factor

Indexed keywords

TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

EID: 84893025330     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000094     Document Type: Article
Times cited : (23)

References (29)
  • 1
    • 0028064764 scopus 로고
    • A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
    • Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392
    • (1994) Blood. , vol.84 , pp. 1361-1392
    • Harris, N.L.1    Jaffe, E.S.2    Stein, H.3
  • 2
    • 1842413105 scopus 로고    scopus 로고
    • A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
    • The Non-Hodgkin's Lymphoma Classification Project
    • The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
    • (1997) Blood. , vol.89 , pp. 3909-3918
  • 3
    • 0028790440 scopus 로고
    • Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
    • Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 1995;333:1540-1545
    • (1995) N Engl J Med. , vol.333 , pp. 1540-1545
    • Philip, T.1    Guglielmi, C.2    Hagenbeek, A.3
  • 4
    • 0027444652 scopus 로고
    • A predictive model for aggressive non-Hodgkin's lymphoma
    • The International Non-Hodgkin's Lymphoma Prognostic Factors Project
    • The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.
    • (1993) N Engl J Med. , vol.329 , pp. 987-994
  • 5
    • 0030031130 scopus 로고    scopus 로고
    • Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma
    • Pettengell R, Radford JA, Morgenstern GR, et al. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol. 1996;14:586-592.
    • (1996) J Clin Oncol. , vol.14 , pp. 586-592
    • Pettengell, R.1    Radford, J.A.2    Morgenstern, G.R.3
  • 6
    • 0028012062 scopus 로고
    • Prognostic factors in aggressive non-Hodgkin's lym-phoma: Who has "high-risk" disease?
    • Shipp MA. Prognostic factors in aggressive non-Hodgkin's lym-phoma: who has "high-risk" disease? Blood. 1994;83:1165-1173.
    • (1994) Blood. , vol.83 , pp. 1165-1173
    • Shipp, M.A.1
  • 8
    • 0015150080 scopus 로고
    • Report of the committee on hodgkin's disease staging classification
    • Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971;31:1860-1861.
    • (1971) Cancer Res. , vol.31 , pp. 1860-1861
    • Carbone, P.P.1    Kaplan, H.S.2    Musshoff, K.3
  • 9
    • 9144237554 scopus 로고    scopus 로고
    • Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
    • Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004; 103:275-282.
    • (2004) Blood. , vol.103 , pp. 275-282
    • Hans, C.P.1    Weisenburger, D.D.2    Greiner, T.C.3
  • 10
    • 0036464704 scopus 로고    scopus 로고
    • De novo CD5+ diffuse large B-cell lymphoma: A clinicopathologic study of 109 patients
    • Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99:815-821.
    • (2002) Blood. , vol.99 , pp. 815-821
    • Yamaguchi, M.1    Seto, M.2    Okamoto, M.3
  • 11
    • 0023916786 scopus 로고
    • Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation
    • Tracey KJ, Wei H, Manogue KR, et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med. 1988;167:1211-1227.
    • (1988) J Exp Med. , vol.167 , pp. 1211-1227
    • Tracey, K.J.1    Wei, H.2    Manogue, K.R.3
  • 12
    • 76949084622 scopus 로고    scopus 로고
    • TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion
    • Wu Y, Zhou BP. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer. 2010;102:639-644.
    • (2010) Br J Cancer. , vol.102 , pp. 639-644
    • Wu, Y.1    Zhou, B.P.2
  • 13
    • 2942675065 scopus 로고    scopus 로고
    • Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer
    • Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat Res. 2004;119:139-173.
    • (2004) Cancer Treat Res. , vol.119 , pp. 139-173
    • Shishodia, S.1    Aggarwal, B.B.2
  • 14
    • 0025737582 scopus 로고
    • Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha
    • Ryffel B, Brockhaus M, Durmuller U, et al. Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha. Am J Pathol. 1991;139:7-15.
    • (1991) Am J Pathol. , vol.139 , pp. 7-15
    • Ryffel, B.1    Brockhaus, M.2    Durmuller, U.3
  • 15
    • 0023229234 scopus 로고
    • Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes
    • Cuturi MC, Murphy M, Costa-Giomi MP, et al. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med. 1987;165: 1581-1594.
    • (1987) J Exp Med. , vol.165 , pp. 1581-1594
    • Cuturi, M.C.1    Murphy, M.2    Costa-Giomi, M.P.3
  • 16
    • 0024262991 scopus 로고
    • Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells
    • Sung SS, Jung LK, Walters JA, et al. Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J Exp Med. 1988;168:1539-1551.
    • (1988) J Exp Med. , vol.168 , pp. 1539-1551
    • Sung, S.S.1    Jung, L.K.2    Walters, J.A.3
  • 17
    • 0029887909 scopus 로고    scopus 로고
    • Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients
    • Salles G, Bienvenu J, Bastion Y, et al. Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Br J Haematol. 1996;93:352-359.
    • (1996) Br J Haematol. , vol.93 , pp. 352-359
    • Salles, G.1    Bienvenu, J.2    Bastion, Y.3
  • 18
    • 0023937119 scopus 로고
    • Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies
    • Cordingley FT, Bianchi A, Hoffbrand AV, et al. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet. 1988;1:969-971.
    • (1988) Lancet. , vol.1 , pp. 969-971
    • Cordingley, F.T.1    Bianchi, A.2    Hoffbrand, A.V.3
  • 19
    • 0031037239 scopus 로고    scopus 로고
    • Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients
    • Warzocha K, Salles G, Bienvenu J, et al. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol. 1997;15:499-508.
    • (1997) J Clin Oncol. , vol.15 , pp. 499-508
    • Warzocha, K.1    Salles, G.2    Bienvenu, J.3
  • 20
    • 0028801694 scopus 로고
    • TNF and Mae West or: Death from too much of a good thing
    • Tracey KJ. TNF and Mae West or: death from too much of a good thing. Lancet. 1995;345:75-76.
    • (1995) Lancet. , vol.345 , pp. 75-76
    • Tracey, K.J.1
  • 21
    • 0037644804 scopus 로고    scopus 로고
    • Biological functions of tumor necrosis factor cytokines and their receptors
    • Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 2003;14:185-191.
    • (2003) Cytokine Growth Factor Rev. , vol.14 , pp. 185-191
    • Pfeffer, K.1
  • 22
    • 0024593088 scopus 로고
    • Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia
    • Digel W, Stefanic M, Schoniger W, et al. Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood. 1989;73:1242-1246.
    • (1989) Blood. , vol.73 , pp. 1242-1246
    • Digel, W.1    Stefanic, M.2    Schoniger, W.3
  • 23
    • 0028338707 scopus 로고
    • Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells
    • Boussiotis VA, Nadler LM, Strominger JL, et al. Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc Natl Acad Sci USA. 1994;91:7007-7011.
    • (1994) Proc Natl Acad Sci USA. , vol.91 , pp. 7007-7011
    • Boussiotis, V.A.1    Nadler, L.M.2    Strominger, J.L.3
  • 24
    • 0029670119 scopus 로고    scopus 로고
    • Value of the determination of TNF-alpha in the plasma of patients with non-Hodgkins lymphoma
    • Macia J, Gomez X, Esquerda A, et al. Value of the determination of TNF-alpha in the plasma of patients with non-Hodgkins lymphoma. Leuk Lymphoma. 1996;20:481-486.
    • (1996) Leuk Lymphoma. , vol.20 , pp. 481-486
    • Macia, J.1    Gomez, X.2    Esquerda, A.3
  • 25
    • 84862563412 scopus 로고    scopus 로고
    • Multiple cytokine-and chemokine-producing primary testicular diffuse large B-cell lym-phoma, not otherwise specified
    • Nakayama S, Yokote T, Iwaki K, et al. Multiple cytokine-and chemokine-producing primary testicular diffuse large B-cell lym-phoma, not otherwise specified. Leuk Res. 2012;36:e171-e174.
    • (2012) Leuk Res. , vol.36
    • Nakayama, S.1    Yokote, T.2    Iwaki, K.3
  • 26
    • 84858263994 scopus 로고    scopus 로고
    • Hypercalcaemia induced by tumour-derived parathyroid hormone-related protein and multiple cytokines in diffuse large B cell lymphoma, not otherwise specified
    • Nakayama-Ichiyama S, Yokote T, Iwaki K, et al. Hypercalcaemia induced by tumour-derived parathyroid hormone-related protein and multiple cytokines in diffuse large B cell lymphoma, not otherwise specified. Pathology. 2011;43:742-745.
    • (2011) Pathology. , vol.43 , pp. 742-745
    • Nakayama-Ichiyama, S.1    Yokote, T.2    Iwaki, K.3
  • 27
    • 32944461717 scopus 로고    scopus 로고
    • Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
    • Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc. 2006;63:433-442.
    • (2006) Gastrointest Endosc. , vol.63 , pp. 433-442
    • Rutgeerts, P.1    Diamond, R.H.2    Bala, M.3
  • 28
    • 0035832515 scopus 로고    scopus 로고
    • Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial
    • Chaudhari U, Romano P, Mulcahy LD, et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet. 2001;357:1842-1847.
    • (2001) Lancet. , vol.357 , pp. 1842-1847
    • Chaudhari, U.1    Romano, P.2    Mulcahy, L.D.3
  • 29
    • 79958108824 scopus 로고    scopus 로고
    • Advances in rheumatology: New targeted therapeutics
    • Tak PP, Kalden JR. Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther. 2011;13:S5.
    • (2011) Arthritis Res Ther. , vol.13
    • Tak, P.P.1    Kalden, J.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.